Outcome of staged surgical excision with intraoperative histopathologic evaluation for treatment of high risk basal cell carcinoma

Treatment high risk basal cell carcinoma by staged surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201412196403N5

Enrollment

Registered

2015-02-25

Start date

2009-01-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

basal cell carcinoma. Malignant neoplasms

Interventions

staged surgical excision with intraoperative pathologic assesment.

Treatment - Surgery

staged surgical excision with intraoperative pathologic assesment

Eligibility

Sex/Gender

All

Age

15 Years to 70 Years

Inclusion criteria

Inclusion criteria: inclusion criteria included: Pathologically documented basal cell carcinoma and minimally had one risk factor included, diameter more than 2 cm, recurrent lesions, high risk pathologic subtype, high risk location of lesions, morphoic clinical subtype exclusion criteria included: immunodeficiency, pregnancy, age less than 15 and more than 70

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Recurrence. Timepoint: monthly in first year and 3 month thereafter. Method of measurement: Clinical and pathologic assesment.	—

Secondary

Measure	Time frame
Healing. Timepoint: monthly in first year and 3 month thereafter. Method of measurement: clinical and pathologic assesment.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026